Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Clinical experience suggests compounded versions produce equivalent results in terms of weight loss, glucose control, and other benefits
Precautions and Best Practices These capsules are generally safe, but pregnant or breastfeeding women and individuals with pre-existing medical conditions should seek medical advice before use
ArticlePubMed 81
See Ozempic benefits and side effects for complete safety information
US$ 21.35
US$ 23.88
US$ 28.77
US$ 28.86
US$ 20.15
US$ 29.39
US$ 23.68
US$ 23.34
US$ 23.59
US$ 28.60
US$ 27.90
US$ 28.59
